Anti-apoptotic effects of GLP-1RAs In both diabetic and non-diabetic rodent models of cerebral ischemia, exenatide, lixisenatide, semaglutide, and liraglutide increased the expression of the anti-apoptotic factor B-cell lymphoma 2 (Bcl-2) and decreased the expression of the pro-apoptotic factor Bcl-2-associated X protein (Bax), consequently leading to a reduced Bax/Bcl-2 ratio and reduced apoptosis, possibly through ROS reduction and activation of the PI3K/Akt and MAPK pathways [73, 86, 87, 92, 93]
Drucker (Montreal, Canada, 26th June 1956) graduated in Medicine from the University of Toronto in 1980
This article reviews the current evidence, practical considerations, and UK clinical guidance to help you make an informed decision
More advertisements and more information were reaching more patients than ever before
By week 24, only 812% reported ongoing nausea, and most rated it as mild
For any of you fellow science lovers, you can read all about the research here you may have already heard these studies are cellularly fascinating